Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].
作者信息
Hua Xing, Liu Zhen, Zhou Min, Tian Yan, Zhao Pei-Pei, Pan Wen-Hai, Li Chao-Xia, Huang Xiao-Xiao, Liao Ze-Xiao, Xian Qi, Chen Bo, Hu Yue, Leng Lei, Fang Xiao-Wei, Yu Li-Na
机构信息
Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
Department of Pathology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, P.R. China.
出版信息
EBioMedicine. 2021 Oct;72:103665. doi: 10.1016/j.ebiom.2021.103665.
Abstract
摘要
相似文献
1
Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].撤回通知：“LSAMP-AS1通过上调肿瘤抑制因子DCN与微小RNA-183-5p结合以抑制前列腺癌进展”[《电子生物医学》50 (2019) 178 - 190]
EBioMedicine. 2021 Oct;72:103665. doi: 10.1016/j.ebiom.2021.103665.
2
RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN.撤回：LSAMP-AS1 通过上调肿瘤抑制因子 DCN 抑制 microRNA-183-5p 的表达来抑制前列腺癌的进展。
EBioMedicine. 2019 Dec;50:178-190. doi: 10.1016/j.ebiom.2019.10.009. Epub 2019 Nov 12.
3
Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression Up-Regulation of MicroRNA-195-5p.长链非编码RNA AGAP2-AS1沉默通过上调微小RNA-195-5p抑制PDLIM5表达，从而阻碍前列腺癌进展
Front Genet. 2020 Sep 25;11:1030. doi: 10.3389/fgene.2020.01030. eCollection 2020.
4
Retraction notice to "Corrigendum to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78]" [EBioMedicine 55 (2020) 102772].撤回声明：“《对〈MicroRNA-134通过PLXNA1介导的MAPK信号通路预防食管鳞状细胞癌进展〉的勘误》[《E生物医学》46 (2019) 66 - 78]”[《E生物医学》55 (2020) 102772]
EBioMedicine. 2024 May;103:105106. doi: 10.1016/j.ebiom.2024.105106. Epub 2024 Apr 4.
5
Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.肌萎缩蛋白样 1 反义 RNA 1 通过海绵吸附 miR-181a-5p 并调节 PTEN/PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、侵袭和迁移。
Bioengineered. 2021 Dec;12(1):803-814. doi: 10.1080/21655979.2021.1890383.
6
Long non-coding RNA ADAMTS9-AS1 inhibits the progression of prostate cancer by modulating the miR-142-5p/CCND1 axis.长链非编码 RNA ADAMTS9-AS1 通过调节 miR-142-5p/CCND1 轴抑制前列腺癌的进展。
J Gene Med. 2021 May;23(5):e3331. doi: 10.1002/jgm.3331. Epub 2021 Apr 7.
7
Long noncoding RNA ZBED3-AS1 restrains breast cancer progression by targeting the microRNA-513a-5p/KLF6 axis.长链非编码 RNA ZBED3-AS1 通过靶向 microRNA-513a-5p/KLF6 轴抑制乳腺癌进展。
Thorac Cancer. 2021 Oct;12(20):2719-2731. doi: 10.1111/1759-7714.14111. Epub 2021 Aug 24.
8
DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.DLX6-AS1 通过调控 miR-497-5p/SNCG 通路促进前列腺癌细胞增殖。
Environ Toxicol. 2021 Mar;36(3):308-319. doi: 10.1002/tox.23036. Epub 2020 Oct 9.
9
Retraction notice to "Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter" [EBioMedicine 55 (2020) 102694].撤回声明：“长链非编码RNA CDKN2B-AS1通过在CDKN2B启动子中形成RNA-DNA三链体促进动脉粥样硬化斑块形成”[《转化医学杂志》55卷（2020年），第102694页] 。
EBioMedicine. 2024 Jun;104:105193. doi: 10.1016/j.ebiom.2024.105193. Epub 2024 Jun 3.
10
lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.长链非编码RNA FOXD3-AS1通过调控miR-135a-5p/CDK6轴促进非小细胞肺癌进展。
Oncol Lett. 2021 Dec;22(6):853. doi: 10.3892/ol.2021.13114. Epub 2021 Oct 26.
Zotero 插件